RT @Yuz6Yusof: Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy & immunomodulator

Social Author Image

https://pbs.twimg.com/profile_images/917734279056187392/qbUrlWGG.jpg

Tweet Author

Social Author Name

Md Yuzaiful Md Yusof

Tweet Content

Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy & immunomodulatory activity vs TACI-i. Could deplete plasma cell compared to anti-CD20 mAbs in #SLE. Be interesting to see how it’ll fare in future clinical trials #EULAR2021 #OP0039 @RheumNow https://t.co/LnQzO67gwI

Show on Archive Page

On

Display in Search Results

On

PDQ

Off

Topics

RT @Yuz6Yusof: Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy & immunomodulator

Do you get our email newsletter?

RT @Yuz6Yusof: Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy &amp; immunomodulator

RT @Yuz6Yusof: Promising preclinical data of novel dual BAFF/APRIL inihibitor ALPN-303 re:efficacy & immunomodulator